ELI LILLY AND COMPANY LIMITED - Profile & Financials

Accounts Submitted 16 Sept 2025

Confirmation Statement Submitted 17 Nov 2025

Net assets £360.29M £13.40M 2024 year on year

Total assets £640.68M £140.39M 2024 year on year

Total Liabilities £280.39M £126.99M 2024 year on year

Charges 2

1 outstanding 1 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Eli Lilly And Company Limited, Lilly House Basingview Basingstoke Hampshire RG21 4FA United Kingdom

Telephone

0(0)1256315000

Website

lilly.com

Credit Report

Discover ELI LILLY AND COMPANY LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£151.00k

Decreased by £95.00k (-39%)

Net Assets

£360.29M

Increased by £13.40M (+4%)

Total Liabilities

£280.39M

Increased by £126.99M (+83%)

Turnover

£889.00M

Increased by £420.23M (+90%)

Employees

634

Increased by 30 (+5%)

Debt Ratio

44%

Increased by 13 (+42%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

4 active 89 resigned

Show resigned officers

						Status
Christopher J Stokes	Director	American	United Kingdom	47	3 Jul 2024	Active
Karen Ann Alexander	Director	British	England	58	1 Aug 2017	Active
Kristina Mignon Wright	Director	American	England	47	8 Aug 2025	Active
Lisa Marie Broad	Director	British	United Kingdom	53	1 Aug 2022	Active

Shareholders

Shareholders (1)


Eli Lilly Group Limited	100.0%	9,452,196	Ordinary	21 Dec 2017

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Eli Lilly Group Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors As Firm
Significant Influence Or Control As Firm

See All Controllers

Group Structure

ELI LILLY GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors as firm, significant influence or control as firm

ELI LILLY AND COMPANY united states of america

ELI LILLY AND COMPANY LIMITED Current Company

ELI LILLY (BASINGSTOKE) LIMITED united kingdom shares 75 to 100 percent, shares 75 to 100 percent as trust, shares 75 to 100 percent as firm, voting rights 75 to 100 percent, voting rights 75 to 100 percent as trust, voting rights 75 to 100 percent as firm, appoint/remove directors as firm, significant influence or control as firm

ELI LILLY HOLDING COMPANY LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, voting rights 75 to 100 percent as firm, appoint/remove directors as firm, significant influence or control as firm

ELI LILLY LEASING LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors as firm, significant influence or control as firm

ELI LILLY PROPERTY LIMITED united kingdom significant influence or control

ELI LILLY RESOURCES LIMITED united kingdom shares 75 to 100 percent, shares 75 to 100 percent as trust, shares 75 to 100 percent as firm, voting rights 75 to 100 percent, voting rights 75 to 100 percent as trust, voting rights 75 to 100 percent as firm, appoint/remove directors as firm, significant influence or control as firm

EPIDAREX CAPITAL II, LP united kingdom part right to share surplus assets 25 to 50 percent

GREENFIELD PHARMACEUTICALS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors, significant influence or control as firm

LILLY INDUSTRIES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors, significant influence or control as firm

LILLY PROPERTY LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors as firm, significant influence or control as firm

LILLY RESEARCH CENTRE LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

LILLY RESOURCES LIMITED united kingdom shares 75 to 100 percent, shares 75 to 100 percent as trust, shares 75 to 100 percent as firm, voting rights 75 to 100 percent, voting rights 75 to 100 percent as trust, voting rights 75 to 100 percent as firm, appoint/remove directors as firm, significant influence or control as firm

Charges

1 outstanding 1 satisfied

Documents

Company Filings

Date	Category	Description	Document
17 Nov 2025	Confirmation Statement	Confirmation statement made on 2025-11-11 with no updates	View(3 pages)
16 Sept 2025	Accounts	Annual accounts made up to 2024-12-31	View(51 pages)
3 Sept 2025	Officers	Change to director Kristina Mignon Wright on 2025-09-01	View(2 pages)
14 Aug 2025	Officers	Appointment of Kristina Mignon Wright as director on 2025-08-08	View(2 pages)
14 Aug 2025	Officers	Termination of Yuya Nonaka as director on 2025-08-08	View(1 page)